Guosen: The number of subsidies for the application of the trade-in policy continues to increase. Keep an eye on new car releases and third-quarter financial reports.
Guosen Securities released a research report stating that the number of subsidy applications for the old-for-new policy continues to increase; pay attention to the market performance in the third quarter.
Guosen released a research report stating that the number of subsidy applications for the old-for-new policy continues to increase; attention is focused on the third quarter market. In August 2024, China's automobile dealer inventory warning index was 56.2%, a year-on-year decrease of 0.7 percentage points, above the boom and bust line. Since the beginning of this year (1.1-9.8), the number of domestic passenger cars insured has reached 13.832 million, a year-on-year increase of +3.1%; the cumulative number of domestic new energy passenger cars insured has reached 6.18 million, a year-on-year increase of + 40.3%.
Guosen's main points are as follows:
Monthly production and sales: In August 2024, automobile production and sales were 2.492 million and 2.453 million respectively, an increase of 9% and 8.5% month-on-month, and a decrease of 3.2% and 5% year-on-year. Passenger car production and sales were 2.221 million and 2.181 million respectively, with a 9.4% increase month-on-month and a 2.3% and 4% decrease year-on-year; commercial vehicle production and sales were 271,000 and 272,000 respectively, with a 5.7% and 1.4% increase month-on-month and a 9.8% and 12.2% decrease year-on-year; in August, the production and sales of new energy vehicles were 1.092 million and 1.1 million respectively, with year-on-year increases of 29.6% and 30% respectively.
Weekly data: According to the insured data, the weekly (9.2-9.8) passenger car registrations in China were 405,300, a year-on-year increase of +12.8% and a month-on-month decrease of -19.2%; the registrations of new energy passenger cars were 222,400, a year-on-year increase of +57.3% and a month-on-month decrease of -12.4%. Since the beginning of this year (1.1-9.8), the number of domestic passenger cars insured has reached 13.832 million, a year-on-year increase of +3.1%; and the cumulative number of domestic new energy passenger cars insured has reached 6.18 million, a year-on-year increase of +40.3%.
Market this week: This week (2024/09/16-2024/09/20), CS Automobile rose by 2.31%, CS Passenger Car rose by 1.18%, CS Commercial Vehicle rose by 4.34%, CS Automobile Parts rose by 2.68%, CS Automobile Sales and Services rose by 1.85%, CS Motorcycles and Others rose by 2.63%, electric vehicles fell by 0.05%, smart vehicles rose by 2.19%, while the Shanghai and Shenzhen 300 Index rose by 1.32%, and the Shanghai Composite Index rose by 1.21%. CS automobiles outperformed the Shanghai and Shenzhen 300 Index by 0.99 percentage points and the Shanghai Composite Index by 1.1 percentage points, with a decline of 7.23% since the beginning of the year.
Cost tracking and inventory: As of September 10, 2024, the prices of float glass, aluminum ingots, and zinc ingots were -37.4%/-0.4%/+8.1% compared to the same period last year; a month-on-month change of -9.6%/+2.2%/+4.3%. In August 2024, China's automobile dealer inventory warning index was 56.2%, a year-on-year decrease of 0.7 percentage points, above the boom and bust line.
Market focus: 1) Progress in autonomous driving (FSD V12 and its introduction to China, FSD subsequent versions, HW5.0 and Siasun Robot&Automation developments); Tesla plans to launch FSD in China in the first quarter of next year; 2) Model-related: XPeng MONA M03 increased production twice in 10 days, over 10,000 vehicles were taken offline 22 days after listing; NIO Ledian L60, Denza Z9GT listed; 3) Regarding Huawei, Hongmeng Zhihang's vehicle models will achieve full standardization with Huawei's autonomous driving; 4) Other: the number of subsidy applications for the old-for-new policy continues to increase; attention is focused on the third-quarter market.
Risk warning: Risks include a tight automobile supply chain, economic recovery falling short of expectations, and lower-than-expected sales.
Related Articles

HK Stock Market Move | TYK MEDICINES-B (02410) surged over 40%. The key registration phase II clinical results of Eliotinib were recently featured in the WCLC oral presentation.

HK Stock Market Move | BOAN BIOTECH (06955) rose more than 14%. The company currently has sufficient cash reserves and institutions are optimistic about its potential in the FIC innovation pipeline market.

Acquisition of CyberArk (CYBR.US) strengthens platform strategy, internet security giant Palo Alto (PANW.US) enters Wedbush's "Best Investment List".
HK Stock Market Move | TYK MEDICINES-B (02410) surged over 40%. The key registration phase II clinical results of Eliotinib were recently featured in the WCLC oral presentation.

HK Stock Market Move | BOAN BIOTECH (06955) rose more than 14%. The company currently has sufficient cash reserves and institutions are optimistic about its potential in the FIC innovation pipeline market.

Acquisition of CyberArk (CYBR.US) strengthens platform strategy, internet security giant Palo Alto (PANW.US) enters Wedbush's "Best Investment List".
